Hong Kong
· Delayed Price · Currency is HKD Genertec Universal Medical Group Company Statistics
Total Valuation
Genertec Universal Medical Group Company has a market cap or net worth of HKD 9.06 billion.
| Market Cap | 9.06B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Genertec Universal Medical Group Company has 1.89 billion shares outstanding. The number of shares has decreased by -1.68% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.89B |
| Shares Change (YoY) | -1.68% |
| Shares Change (QoQ) | -3.49% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 5.83% |
| Float | 918.13M |
Valuation Ratios
The trailing PE ratio is 4.38 and the forward PE ratio is 4.01.
| PE Ratio | 4.38 |
| Forward PE | 4.01 |
| PS Ratio | 0.64 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | 1.61 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 2.27.
| Current Ratio | 2.93 |
| Quick Ratio | 2.85 |
| Debt / Equity | 2.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.70 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.75%.
| Return on Equity (ROE) | 10.75% |
| Return on Assets (ROA) | 2.68% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 659,198 |
| Profits Per Employee | 102,906 |
| Employee Count | 21,089 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.47% in the last 52 weeks. The beta is 0.68, so Genertec Universal Medical Group Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +12.47% |
| 50-Day Moving Average | 4.85 |
| 200-Day Moving Average | 4.62 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 4,481,922 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genertec Universal Medical Group Company had revenue of HKD 14.19 billion and earned 2.21 billion in profits. Earnings per share was 1.09.
| Revenue | 14.19B |
| Gross Profit | 4.63B |
| Operating Income | 2.85B |
| Pretax Income | 3.14B |
| Net Income | 2.21B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 2.74 billion in cash and 54.46 billion in debt, giving a net cash position of -51.72 billion or -27.34 per share.
| Cash & Cash Equivalents | 2.74B |
| Total Debt | 54.46B |
| Net Cash | -51.72B |
| Net Cash Per Share | -27.34 |
| Equity (Book Value) | 23.95B |
| Book Value Per Share | 10.86 |
| Working Capital | 53.05B |
Cash Flow
In the last 12 months, operating cash flow was 6.86 billion and capital expenditures -1.25 billion, giving a free cash flow of 5.61 billion.
| Operating Cash Flow | 6.86B |
| Capital Expenditures | -1.25B |
| Free Cash Flow | 5.61B |
| FCF Per Share | 2.97 |
Margins
Gross margin is 32.66%, with operating and profit margins of 20.12% and 16.23%.
| Gross Margin | 32.66% |
| Operating Margin | 20.12% |
| Pretax Margin | 22.12% |
| Profit Margin | 16.23% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 39.57% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 7.31%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 7.31% |
| Dividend Growth (YoY) | 2.94% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 1.68% |
| Shareholder Yield | 8.98% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |